CDKN2A and sarcoma: Similarly to the strategy followed for the generation of wild-type sarcoma cells presented in Figure 1, we derived MEFs from p16-3MR (from now on simply called 3MR) and subjected these cells to RAS overexpression and p53 inactivation (RAS+GSE).